• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Methotrexate Triglutamate-[d7]

General Information
Catalog: BLP-006033
Molecular Formula: C30H29D7N10O11
Molecular Weight: 719.71
Chemical Structure
Methotrexate Triglutamate-[d7]
Description Methotrexate Triglutamate-[d7] is the labelled analogue of Methotrexate Triglutamate, which is a metabolite of Methotrexate. Methotrexate is a chemotherapy agent and immunosuppressive agent. It can be used to treat cancer, autoimmune diseases, ectopic pregnancies and medical abortions.
Synonyms Methotrexate D7 Triglutamate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-γ-glutamyl-L-γ-glutamyl-L-glutamic Acid-d7; 4-Amino-10-methylpteroylglutamyl-γ-diglutamic Acid-d7; MTXPG3-d7; NSC 341076-d7
IUPAC Name ((S)-4-carboxy-4-((S)-4-carboxy-4-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl-d3)amino)benzamido-2,3,5,6-d4)butanamido)butanoyl)-L-glutamic acid
Related CAS 41600-14-0 (unlabelled)
Purity 95% by HPLC; 98% atom D
Appearance Solid
Storage Store at-20°C under inert atmosphere

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket